Microbiome Report for Week Ending 8/25/18

Microbiome Report for Week Ending 8/25/18

Source: 
CP Wire
snippet: 

Kaleido Biosciences, a clinical-stage healthcare company leading the development of novel chemistries that drive functions of the microbiome organ, today announced that Alison Lawton, Kaleido’s president and chief operating officer (COO), has been appointed to succeed Michael Bonney as chief executive officer.